The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 16.50
High: 16.50
Low: 16.50
Prev. Close: 16.50
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

19 Dec 2022 07:00

RNS Number : 0779K
Insig AI Plc
19 December 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Insig AI Plc / EPIC: INSG / Market: AIM

 

19 December 2022

INSIG AI PLC

("INSG" or the "Company")

Unaudited Interim Results for the Six Months ended 30 September 2022

 

Insig AI plc (AIM:INSG), the data science and machine learning solutions company serving the asset management industry, is pleased to announce its unaudited interim results for the six months ended 30 September 2022 and to provide an update on the Company's progress post the half year end.

 

Highlights

 

· Loss for the period after income tax £2.8 million

· Operating loss before tax of £2.6 million after charging depreciation and amortisation of £1.4 million

· Cash and cash equivalents at period end of £0.15 million

· Positive advanced discussions to re-negotiate and extend existing Convertible Loan Note agreements.

 

Insig AI's Chief Executive, Colm McVeigh commented: "Our strong machine learning AI capability delivers high impact fintech data science solutions resulting in better investment outcomes and operational transformation for our asset managers customers. Despite an increasingly difficult macro-economic backdrop and with us taking a cautious approach, we anticipate growing revenues throughout 2023."

 

Chairman's statement

 

In September, when we published our full year results to 31 March, we set out how we had evolved and refined our technology offering and sales processes to be able to take advantage of the opportunities available to us in our addressable markets. As the asset management industry increasingly requires technology to deliver competitive differentiation and adapt to evolving standards, we are able to apply our advanced analytical tools, machine learning innovative data gathering and processing in ways that can benefit our target customer base, offering asset managers competitive advantage as well as efficiencies. We apply our deep domain expertise in ESG, fintech data science, machine learning and cloud data infrastructure so our customers can achieve sustainable investment decisions and high impact operational transformation through AI and data solutions.

 

Over the last year, the Company has invested heavily to build a repository of machine learning ESG company disclosures on more than 2,500 global businesses. Our database now encompasses all constituents of the S&P 500, the STOXX 600 and the FTSE 100/250/350 together with hundreds of non-listed corporates. The Company is confident that this repository can be utilised to deliver a long term revenue stream. Last month, we explained that having now secured this capability and capacity, we are able to flex our costs based on orders received.

 

In February, we announced a landmark agreement with CarVal Investors, L.P. ("CarVal") to develop and launch a new line of high yield ("HY") and investment grade ("IG") ESG scoring tools to be used by CarVal to optimise HY and/or IG portfolios based on ESG considerations. In May, these scoring tools were successfully delivered. Our share of fees are based on CarVal's assets under management ("AUM") raised in connection with these HY and/or IG focused investment pools. We anticipate that as CarVal secures mandates, our fees will increase commensurably and continue for several years. 

 

Last month, we described the nascent nature of the ESG space. Whilst improved disclosures and an end to greenwashing will be both welcome and inevitable, timings remain uncertain. One of our frustrations is that the positive feedback we receive on our ESG scoring tool, which provides objective evidence of a company's ESG disclosures to market participants, asset managers, corporates and to regulators, does not translate into immediate revenues. When an end to greenwashing becomes mandatory, our ESG diagnostics should become a go-to solution. At present, the optimal route to market is through partnerships with large corporate consultancies. Whilst such sales cycles are inevitably lengthy, they are able to deliver distribution on a broad and substantial scale.

 

Whilst in recent months, the recessionary narrative has taken hold, understandably the ESG agenda has slipped down the priorities of many businesses. However, it remains all too easy for an asset manager to label a fund "ESG compliant" but to do so, without a methodology that drills down to each element of ESG, thereby exposes the asset manager to a lack of evidence of compliance. This can expose not only a business but also its directors to immense reputational and financial damage. That is why increasing regulation is both necessary and inevitable.

 

Financial performance

 

For the six months ending 30 September 2022, we are reporting a total comprehensive loss from all activities of £2.8 million which includes depreciation and amortisation of £1.4 million, deferred tax of £0.2 million and a profit from the Group's non-core school sport coaching facility, Sport in Schools Limited ("SSL") of £0.02 million. The Directors are not recommending the payment of a dividend.

 

Pantheon Leisure Plc ("Pantheon")

 

Insig holds 85.87% of the issued share capital of Pantheon which in turn owns 100% of Sport in Schools Limited ("SSL"). Pantheon's results are consolidated into the Group accounts.

 

Sport in Schools Limited ("SSL")

 

Profit recognised in the period was £0.02 million compared with £0.1 million during the comparable period. The current period outturn reflects a significant marketing investment which is expected to translate into increased revenues from spring 2023.

 

Funding

 

In March 2022, we announced that the Board had decided to secure a long-term revenue agreement based on AUM at the expense of revenues that could have been recognised in the year under review. Whilst this had a detrimental effect on immediate cash flows, the quantum and longevity of receipts is expected to be considerably more than those foregone short term revenues.

 

In May, I provided the Company with an unsecured convertible loan facility of £1.0 million. The key terms were conversion at the higher of 35p per share and the prevailing share price at the time of conversion and a coupon of 5 per cent. per annum on funds drawn down. The first draw down took place in early May. In June, the Company announced that it had been approached by David Kyte, a long-term shareholder with an offer of funding of £0.5 million, on the same terms as my own facility. These loan facilities have been fully utilised and are due for repayment on 31 December 2022. As announced in the Company's year-end results in September, the Board continues to believe it would not be in the best interest of all shareholders to conduct an equity raise in the short term. As such, the Board is pleased to have recently received proposals from myself and David Kyte to extend the current convertible loan facilities expiring on 31 December 2022 by 12 months. Following the release of today's interim results, the Board is considering these proposals and is expected to make a further announcement very shortly.

 

For myself, the terms of the extension include:

 

· interest owed on the first convertible loan facility to be rolled up into the loan expiring on 31 December 2023,

· interest of 8 per cent. per annum from 5 per cent. per annum, which reflects the 2.25 per cent increase in UK base rates since May 2022 and the deterioration in debt capital markets and funding environment.

· a conversion price of 20p, which represents a 17.6 per cent. premium to the current share price of 17p, being the closing share price on 16 December 2022, and 1,666,667 warrants expiring on 31 December 2025 exercisable at a price of 30p, which represents a 76.5 per cent premium to the current share price.

 

For David Kyte's facility, the terms of extension include:

 

· interest owed on the first convertible loan facility to be rolled up into the loan expiring on 31 December 2023,

· interest of 8 per cent. per annum from 5 per cent. per annum, which reflects the 2.25 per cent increase in UK base rates since May 2022 and the deterioration in debt capital markets and funding environment.

· a conversion price of 18p, which represents a 5.9 per cent. premium to the current share price of 17p, being the closing share price on 16 December 2022, and 1,388,889 warrants expiring on 31 December 2025 exercisable at a price of 25p, which represents a 47.1 per cent premium to the current share price.

 

 

In September, I provided a loan facility of up to £0.75 million. The key terms were a conversion price of 35p per share and a coupon of 5 per cent. per annum on funds drawn down. This loan is secured against the share capital held by the Company in Westside Sports Limited, which has interests in Ultimate Player Limited, Pantheon Leisure plc, Sport in Schools Limited and the Elms Group Limited. In October, £0.36 million of this facility was drawn down. As of today, £0.39 million remains available for drawdown.

 

Last month, the Company announced that the Board believed that no further working capital would be required to support the operations of the business in the short and medium term, as the business is expected to become cash flow positive from Q2 2023. The Board remains of that view based on the combination of committed revenues, the sales pipeline and more recent prospects. The Board continues to closely monitor the conversions of these sales opportunities into revenue.

 

Prospects

 

Last month, we set out that we had prioritised and accelerated the timeline to expected profitability of the Group. This was underpinned by our expectations for the receipt of recurring revenues from sharing of management fees. Substantial investment over the last 18 months should result in payback with these revenues expected to commence next summer. Over subsequent quarters, these should grow substantially. This underpinning of revenues should position us to withstand weak investor sentiment in global markets. Market uncertainty, harsher fundraising conditions than in the recent past and recessionary fears mean that we are adopting a cautious approach. Against a backdrop of budget constraints, we are mindful of how such uncertainty can result in inertia. Nevertheless, we have strong evidence from progressive asset management clients that our offerings add substantial value, can generate alpha, provide improved access to financial data and reduce regulatory risk.

 

Richard Bernstein

Non-Executive Chairman

19 December 2022

 

 For further information, please visit www.insg.ai or contact:

Insig AI plc

Colm McVeigh, CEO

colm.mcveigh@insg.ai

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Philips

+44 (0) 203 829 5000

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

Notes

6 months to 30 September 2022 Unaudited

£

6 months to 30 September 2021 Unaudited

£

Continuing operations

Revenue

953,563

895,750

Cost of sales

(359,411)

(477,374)

Gross profit

594,152

418,376

Administration expenses

(3,224,761)

(2,419,044)

Other gains/(losses)

47,533

1,436,000

Other income

201

106,348

Operating loss

(2,582,875)

(458,320)

Finance income

-

3,892

Finance costs

(15,483)

(15,001)

Loss before exceptional item

(2,598,358)

(469,429)

Exceptional items - non - recurring costs

-

(374,765)

Loss before income tax

(2,598,358)

(844,194)

Deferred tax

(208,738)

-

Tax credits

-

194,133

Loss for the period after income tax

(2,807,096)

(650,061)

Total comprehensive loss attributable to owners of the Parent

(2,810,503)

(663,062)

Total comprehensive profit/(loss) attributable to non-controlling interests

3,407

13,001

 

Basic and diluted

5

(2.660)p

(0.0074)p

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

 

 

Notes

As at

30 September 2022 Unaudited

£

As at

31 March 2022 Audited

£

As at

30 September 2021 Unaudited

£

Non-Current Assets

 

 

Property, plant and equipment

66,483

65,665

347,467

Right of Use Assets

33,406

38,545

-

Intangible assets

7

37,693,489

38,217,155

31,712,235

37,793,378

38,321,365

32,059,702

Current Assets

Trade and other receivables

226,774

289,819

1,594,580

Cash and cash equivalents

150,084

473,390

2,273,661

376,858

763,209

3,868,241

Total Assets

38,170,236

39,084,574

35,927,943

 

 

Non-Current Liabilities

 

Lease liabilities

24,930

29,641

295,748

Borrowings

-

-

195,038

Deferred tax liabilities

4,368,826

4,160,088

617,304

4,393,756

4,189,729

1,108,090

Current Liabilities

 

Trade and other payables

984,546

810,332

523,641

Lease liabilities

8,000

8,000

8,333

Borrowings

-

-

36,000

Convertible loans

8

1,514,517

-

-

 

2,507,063

818,332

567,974

Total Liabilities

6,900,819

5,008,061

1,676,064

Net Assets

31,269,417

34,076,513

34,251,879

Capital and Reserves Attributable to

Equity Holders of the Company

 

Share capital

3,109,804

3,109,804

3,039,579

Share premium

39,077,403

39,077,403

35,154,043

Other reserves

325,583

325,583

975,117

Retained losses

(11,194,113)

(8,383,610)

(4,864,193)

Equity attributable to shareholders of the parent

31,318,677

34,129,180

34,304,546

Non-controlling interests

(49,260)

(52,667)

(52,667)

Total Equity

31,269,417

34,076,513

34,251,879

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

Note

Share capital

£

Share premium

£

Other reserves

£

Retained losses

£

Total equity

£

Non Controlling Interest

£

Total equity

£

Balance as at 1 April 2021

 

2,479,664

3,039,531

427,727

(4,201,131)

1,745,791

(65,668)

1,680,123

Loss for the period

-

-

-

(663,062)

(663,062)

13,001

(650,061)

Total comprehensive loss for the period

 

-

-

-

(663,062)

(663,062)

13,001

(650,061)

Issue of shares

 

559,915

32,571,612

-

-

33,131,527

-

33,131,527

Share issue costs

 

-

(434,900)

-

-

(434,900)

-

(434,900)

Merger reserves on acquisition of Insig Partners Ltd

 

-

(22,200)

671,733

-

649,533

-

649,533

Equity component of convertible loan notes

 

-

-

(124,343)

-

(124,343)

-

(124,343)

Total transactions with owners, recognised in equity

 

559,915

32,114,512

547,390

-

33,221,817

-

33,221,817

Balance as at 30 September 2021

 

3,039,579

35,154,043

975,117

(4,864,193)

34,304,546

(52,667)

34,251,879

 

 

 

 

 

 

 

 

 

Balance as at 1 April 2022

 

3,109,804

39,077,403

325,583

(8,383,610)

34,129,180

(52,667)

34,076,513

Loss for the period

-

-

-

(2,810,503)

(2,810,503)

3,407

(2,807,096)

Total comprehensive loss for the period

 

-

-

-

(2,810,503)

(2,810,503)

3,407

(2,807,096)

Balance as at 30 September 2022

 

3,109,804

39,077,403

325,583

(11,194,113)

31,318,677

(49,260)

31,269,417

 

 

 

 

 

 

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

 

 

 

 

Notes

6 months to 30 September 2022

Unaudited

£

6 months to 30 September 2021 Unaudited

£

Cash flows from operating activities

 

 

Loss before taxation

(2,810,503)

(844,194)

Adjustments for:

Depreciation and amortisation

1,371,290

1,178,395

Increase in deferred tax provision

198,738

-

Minority interest

3,407

-

Finance income

-

(3,892)

Finance expense

15,458

15,001

Working capital on subsidiary acquisition

-

(410,015)

Increase in trade and other receivables

7,545

(105,230)

Increase/(decrease) in trade and other payables

239,714

(42,081)

Realised gain on share investment

-

(1,436,000)

Net cash used in operations

(974,351)

(1,648,016)

Cash flows from investing activities

Purchase of property, plant and equipment

(263)

(6,456)

Development expenditure

7

(834,952)

(1,181,756)

Finance income

-

3,892

Net cash used in investing activities

(835,215)

(1,184,320)

Cash flows from financing activities

 

Funds from share issues

-

6,145,491

Cash consideration to shareholders of the acquired company

-

(1,442,478)

Share issue costs paid

-

(434,901)

Finance expense

-

(9,836)

Repayment of leasing liabilities and bank borrowings

(13,740)

(87,232)

Convertible loan note

1,500,000

-

Net cash generated from financing activities

1,486,260

4,171,044

Net decrease in cash and cash equivalents

(323,306)

1,338,708

Cash and cash equivalents at beginning of period

473,390

934,953

Cash and cash equivalents at end of period

150,084

2,273,661

 

 

 

 

NOTES TO THE INTERIM FINANCIAL STATEMENTS

 

1. General Information

 

Insig AI plc is a data science and machine learning company listed on the AIM Market of the London Stock Exchange.

 

The Company is domiciled in the United Kingdom and incorporated and registered in England and Wales, with registration number 03882621. The Company's registered office is Suite 1, 15 Ingestre Place, London, W1F 0DU.

 

2. Basis of Preparation

 

The condensed consolidated interim financial statements have been prepared in accordance with the requirements of the AIM Rules for Companies. As permitted, the Company has chosen not to adopt IAS 34 "Interim Financial Statements" in preparing this interim financial information. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 March 2022, which have been prepared in accordance with UK adopted international accounting standards.

 

The interim financial information set out above does not constitute statutory accounts within the meaning of the Companies Act 2006. It has been prepared on a going concern basis in accordance with the recognition and measurement criteria of UK adopted international accounting standards.

 

Statutory financial statements for the year ended 31 March 2022 were approved by the Board of Directors on 8 September 2022 and delivered to the Registrar of Companies. The report of the auditors on those financial statements was unqualified with a material uncertainty in relation to the Company's ability to continue as a going concern. The condensed interim financial statements are unaudited and have not been reviewed by the Company's auditor. 

 

Going concern

 

These financial statements have been prepared on the going concern basis. Given the Group's current cash position and its demonstrated ability to raise capital, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting preparing the condensed interim financial statements for the period ended 30 September 2022.

 

Notwithstanding the above, a material uncertainty exists that may cast significant doubt on the Groups ability to continue as a going concern and, therefore, that the Group may be unable to realise their assets or settle their liabilities in the ordinary course of business. As a result of their review, and despite the aforementioned material uncertainty, the Directors have confidence in the Groups forecasts and have a reasonable expectation that the Group will continue in operational existence for the going concern assessment period and have therefore used the going concern basis in preparing these consolidated financial statements.

 

The factors that were extant at 31 March 2022 are still relevant to this report and as such reference should be made to the going concern note and disclosures in the 2022 Annual Report and Financial Statements ("2022 Annual Report").

 

Risks and uncertainties

 

The Board continuously assesses and monitors the key risks of the business. The key risks that could affect the Company's medium term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company's 2022 Annual Report and Financial Statements, a copy of which is available on the Company's website: www.insgai.com. The key financial risks are liquidity risk, credit risk, interest rate risk and fair value estimation.

 

Critical accounting estimates

 

The preparation of condensed interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the end of the reporting period. Significant items subject to such estimates are set out in Note 2 of the Company's 2022 Annual Report and Financial Statements. The nature and amounts of such estimates have not changed significantly during the interim period.

 

3. Accounting Policies

 

Except as described below, the same accounting policies, presentation and methods of computation have been followed in these condensed interim financial statements as were applied in the preparation of the Company's annual financial statements for the period ended 31 March 2022.

 

3.1 Changes in accounting policy and disclosures

 

(a) New and amended standards adopted by the Group and Company

The International Accounting Standards Board (IASB) issued various amendments and revisions to International Financial Reporting Standards and IFRIC interpretations. The amendments and revisions were applicable for the period ended 31 March 2022 but did not result in any material changes to the financial statements of the Group or Company.

 

Of the other IFRS and IFRIC amendments, none are expected to have a material effect on future Group or Company Financial Statements. 

 

(b) New standards, amendments and Interpretations in issue but not yet effective or not yet endorsed and not early adopted

The standards and interpretations that are issued, but not yet effective, up to the date of issuance of the condensed interim financial statements are listed below. The Group intends to adopt these standards, if applicable when they become effective.

Standard

Impact on initial application

Effective date

IAS 8 (amendments)

Accounting estimates

1 January 2023

 

 

None are expected to have a material effect on the Group or Company Financial Statements.

 

4. Dividends

 

No dividend has been declared or paid by the Company during the six months ended 30 September 2022 (six months ended 30 September 2021: £nil).

 

5. Loss per Share

 

The calculation of loss per share is based on a retained loss of £2,810,503 for the six months ended 30 September 2022 (six months ended 30 September 2021: £663,062) and the weighted average number of shares in issue in the period ended 30 September 2022 of 105,675,645 (six months ended 30 September 2021: 89,182,000).

 

No diluted earnings per share is presented for the six months ended 30 September 2022 or six months ended 30 September 2021 as the effect on the exercise of share options would be to decrease the loss per share.

 

6. Business segment analysis

 

 

Machine learning and Data services

£

Sport in Schools

 

£

Total

 

£

Revenue

289,524

664,039

953,563

Costs of sales

(2,545)

(356,866)

(359,411)

Administrative expenses

(2,945,323)

(279,438)

(3,224,761)

Other gains/(losses)

58,570

(11,037)

47,533

Other income

-

201

201

Finance costs

(15,483)

-

(15,483)

Profit/(Loss) before tax per reportable segment

(2,615,257)

16,899

(2,598,358)

 

 

7. Intangible assets

 

The movement in capitalised intangible costs during the period was as follows:

 

Cost and Net Book Value

Goodwill

£

Technology assets

£

Customer relationships

£

Databases

£

Total

£

Balance as at 1 April 2022

21,621,803

14,420,352

1,133,000

1,042,000

38,217,155

Additions

-

834,952

-

-

834,952

Amortisation

-

(1,233,273)

(47,202)

(78,143)

(1,358,618)

As at 30 September 2022

21,621,803

14,022,031

1,085,798

963,857

37,693,489

8. Convertible Loans

 

 

 

 

30 September 2022

31 March 2022

 

 

£

£

 

Not later than one year:

 

Convertible loan note

1,500,000

-

 

Convertible loan note interest

14,517

-

 

Total

1,514,517

-

 

 

On the 4 May 2022, the Company entered into a formal agreement for a £1.0m convertible loan note to be provided by Richard Bernstein, Non-Executive Chairman of the Company.

 

On 17 June 2022, the Company entered into a convertible loan facility agreement with David Kyte, a long-term shareholder in the Company for £500,000.

 

9. Events after the balance sheet date

On 12 October 2022, £100,000 was drawn down on the convertible loan facility for a total of £750,000 as announced on 12 September 2022.

On 26 October 2022, £260,000 was drawn down on the convertible loan facility for a total of £750,000 as announced on 12 September 2022.

10. Approval of interim financial statements

The Condensed interim financial statements were approved by the Board of Directors on 18 December 2022.

 

11.  Availability of this announcement

Copies of this announcement are available from Insig AI website at www.insg.ai.

 

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR MZMMZGRVGZZZ
12
Date   Source Headline
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSNew Contract Win
3rd Nov 20227:00 amRNSTrading update
26th Oct 20227:00 amRNSConvertible Loan Facility drawdown
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.